$8.540
-0.010 (-0.12%)Al cierre
Rentabilidad y márgenes de CMRX
Evaluating the bottom line, Chimerix Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -43073.68%, while the net margin is -40270.18%. These profitability ratios, combined with a Return on Equity (ROE) of -56.17%, provide a clear picture of how effectively CMRX converts its operational activities into shareholder value.
Comparativa sectorial de CMRX
In the context of the broader market, CMRX competes directly with industry leaders such as ZYME and NRIX. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CMRX's gross margin of 100.00% stands against ZYME's 100.00% and NRIX's 100.00%. Such benchmarking helps identify whether Chimerix Inc is trading at a premium or discount relative to its financial performance.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.